{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:14:07Z","timestamp":1787015647489,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3626,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/jth.12060","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T10:52:16Z","timestamp":1352371936000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["The risk of venous thrombosis in women over 50\u2003years old using oral contraception or postmenopausal hormone therapy"],"prefix":"10.1016","volume":"11","author":[{"given":"R.E.J.","family":"ROACH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.M.","family":"LIJFERING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"HELMERHORST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"CANNEGIETER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"ROSENDAAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van HYLCKAMA VLIEG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12060_bb0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population\u2010based study","volume":"5","author":"Naess","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12060_bb0015","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2010control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/jth.12060_bb0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral\u2010contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/jth.12060_bb0025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case\u2010control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/jth.12060_bb0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/jth.12060_bb0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen\/progestin Replacement Study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12060_bb0040","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta\u2010analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/jth.12060_bb0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12060_bb0050","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/jth.12060_bb0055","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/jth.12060_bb0060","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot\u2010medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12060_bb0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.maturitas.2009.05.001","article-title":"Hormonal contraceptive regimens in the perimenopause","volume":"63","author":"Hardman","year":"2009","journal-title":"Maturitas"},{"key":"10.1111\/jth.12060_bb0070","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/jth.12060_bb0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1538-7836.2005.01268.x","article-title":"Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case\u2010control study","volume":"3","author":"Douketis","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12060_bb0080","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/jth.12060_bb0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta\u2010analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12060_bb0090","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"Bezemer","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12060_bb0095","unstructured":"Rothman KJ. Types of epidemiologic study. Epidemiology: An Introduction. New York: Oxford University Press, 2002; 73\u201387."},{"key":"10.1111\/jth.12060_bb0100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0021-9681(85)90039-6","article-title":"The \u201ccase\u2010control\u201d study: valid selection of subjects","volume":"38","author":"Miettinen","year":"1985","journal-title":"J Chronic Dis"},{"key":"10.1111\/jth.12060_bb0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/jth.12060_bb0110","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jama.299.11.1306","article-title":"Gene variants associated with deep vein thrombosis","volume":"299","author":"Bezemer","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/jth.12060_bb0115","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/aje\/kwg066","article-title":"Age at natural menopause and all\u2010cause mortality: a 37\u2010year follow\u2010up of 19,731 Norwegian women","volume":"157","author":"Jacobsen","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1111\/jth.12060_bb0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jth.12060_bb0125","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose\u2010response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.12060_bb0130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-136-9-200205070-00011","article-title":"Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta\u2010analysis for the U.S. Preventive Services Task Force","volume":"136","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12060_bb0135","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.0007-1048.2002.03356.x","article-title":"Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis","volume":"116","author":"Rosendaal","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12060_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/gme.0b013e31822b721f","article-title":"Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women","volume":"19","author":"Guimaraes","year":"2012","journal-title":"Menopause"},{"key":"10.1111\/jth.12060_bb0145","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.ATV.0000018301.91721.94","article-title":"Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease","volume":"22","author":"Herrington","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12060_bb0150","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/jth.12060_bb0155","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.ATV.0000245792.62517.3b","article-title":"Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women","volume":"26","author":"Smith","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12060_bb0160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1538-7836.2006.01933.x","article-title":"Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study","volume":"4","author":"Canonico","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12060_bb0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen\u2010induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12060_bb0170","doi-asserted-by":"crossref","first-page":"22949","DOI":"10.1074\/jbc.271.38.22949","article-title":"An antifibrinolytic mechanism describing the prothrombotic effect associated with factor V Leiden","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12060_bb0175","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1161\/01.CIR.0000148781.87906.C0","article-title":"Factor V Leiden inhibits fibrinolysis in vivo","volume":"110","author":"Parker","year":"2004","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12060","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12060","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622052539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622052539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12060\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:03:56Z","timestamp":1761534236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622052539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1538783622052539"],"URL":"https:\/\/doi.org\/10.1111\/jth.12060","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of venous thrombosis in women over 50\u2003years old using oral contraception or postmenopausal hormone therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}